Back to 
Skandinaviska Enskilda Banken AB (publ)
Skandinaviska Enskilda Banken AB (publ)
RVMD
9 quarters
Position history for Skandinaviska Enskilda Banken AB (publ)'s holdings in Revolution Medicines, Inc.
No. Skandinaviska Enskilda Banken AB (publ) exited its RVMD (Revolution Medicines) position in Q3 2025. Its Q2 2025 13F listed 29,705 shares worth $1.1M. Skandinaviska Enskilda Banken AB (publ) first reported RVMD in Q3 2023 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$519,000
Total Shares Change
-18,767
Quarter-by-Quarter History
Other major holders of RVMD: BlackRock, Inc., Farallon Capital Management, L.L.C., FMR LLC, Baker Bros. Advisors LP, Jupiter Topco LLC